UK Commercial Pipeline update
How does this Q&A work:
This company invites all interested, both current investors and potential investors to participate in this event, ask questions directly on this page before the event starts and upvote those questions you would like addressed.
The company will address as many questions as possible, and focus on those questions most wanted by investors.
Speakers at this event:
2 Questions
Dec. 11, 2024
Do Brain+ have a saving value, on CST treatment per patient, when comparing analoge CST treatments, to digital run CST treatments, and what would those savings be, in percentages?
Dec. 11, 2024
Dear Brain+,
Ofcourse diffecult to ask questions before we have seen todays presentation but if a repetition then please ignore :-)
You touched base on the subject at last call - but please :
1/ update us on timeline for a new issuance of stock / funding need.
2/ can there be any potential "happenings" - like a large sale e.g. - that would cancel this issuance / funding need
3/ what is the funding for ? the running costs or more R&D within Brain+ ?
4/ Brain+ did states at some time that a UK sale would be at "end of November " which was adjusted to "End of Year" I guess - if any official data available on this - or even an indication - please share.
kind regards, Niels